pretickt

Is AXON a good stock to buy?

Axon Enterprise, Inc. · end-of-day data as of Nov 13, 2026

Axon
$25.69B
$315.43+2.7%
Nov 13, 2026 · close
$400$600SepOctNov9:3016:003 months -49.1%Nov 13 · close
▲ 4
  • PT$641.00 +103.2%
  • ConsensusBuy · 22
  • P/E vs own-55.6%
  • RSI30
Neutral
  • Earnings in102d
  • P/E101.1x
  • Resistance+20.9%
  • Off 52w high-52.6%
  • Volume0.8x
  • Bollingerlower half
  • FCF yield+0.3%
  • Trendsideways
  • 52w range$291–$665
  • ATR+7.2%
  • Off ATH-64.4%
▼ 6
  • P/E vs sector+269.4%
  • Insiders-$21.23M
  • News
  • MAs0 of 4
  • MACD-8.98
  • Sector▼ -11.7%

Updates with the 15-min delayed price. Not a forecast or investment advice.

Is Axon a good stock to buy?

Axon is strong on 3 of the 5 questions about the business; weak on economics. The price is low: 101.1 times its earnings, below its 3-year median of 131.2 (Nov 13, 2026). pretickt does not say whether to buy or sell.

  1. Demand growing
  2. Advantage hard to copy
  3. Economics profits falling
  4. Execution mixed
  5. Fragility sturdy
  6. Price below its usual
DemandDo people want more of what it sells?growing

AXON sales growth revenue growth

+33%a year, for the last 3 years

Axon's sales grew 33% a year for 3 years, to $2.78B in fiscal 2025.

AXON analysts' forecast revenue estimates

+30%the sales they expect next fiscal year, on the last

Analysts expect Axon's sales to grow 30% to $3.63B in fiscal 2026 (13 analysts).

AXON competitors

pretickt analysis+34%its sales in 12 months, on a year before

Axon's sales grew 34% in the 12 months to Sep 30, 2026, faster than Woodward (+22%), Curtiss-Wright (+11%) and Textron (+9%), slower than Rocket Lab (+59%).

AXON sales by business revenue by segment

43%of its sales from Software And Sensors

Software And Sensors brought Axon 43% of its sales in fiscal 2025; TASER X2 33%.

Advantage moatIs it hard to copy?hard to copy

AXON margin on each sale gross margin

59%left after making the product

Axon kept 59% of each sale after making the product in the 12 months to Sep 30, 2026; its competitors' median is 33%.

EconomicsDoes it make good money?profits falling

AXON cash generated free cash flow

$80.91Mcash left after investing, last 12 months

Axon generated $80.91M of free cash flow in the 12 months to Sep 30, 2026, less than its reported profit.

AXON profit per share

-68%in its last fiscal year

Axon's earnings per share fell 68% in fiscal 2025, to $1.52.

ExecutionDoes it deliver what it promises?mixed

AXON earnings vs estimates

5 of 7quarters above the analysts' estimate

Axon beat the analysts' profit estimate in 5 of 7 quarters, the latest on Nov 5, 2026; 1 quarter with one-time gains or charges is left out.

AXON insider selling

-$119Msold, net, by its executives in 12 months

Axon's executives and directors sold a net $119M of shares in the 12 months to Nov 13, 2026; none bought.

AXON number of employees

+24%more people in a year

Axon had 5,100 employees at the end of fiscal 2025, 24% more than a year before.

AXON CEO pay

$40Kfor fiscal 2025, 0% of it in stock and options

Axon paid its CEO $40K for fiscal 2025, 0% of it in stock and options.

Fragility risksCould something break it?sturdy

AXON financial health Altman Z-score

4.2Altman Z-score, safe above 3

Axon's Altman Z-score is 4.2 (Nov 13, 2026), above 3, where the safe zone starts.

AXON biggest customers

under 10%of sales from any one customer

No customer made 10% of Axon's sales in fiscal 2025.

AXON shareholders institutional ownership

pretickt analysis
  • Vanguard11.0% ▲
  • BlackRock10.4% ▲
  • State Street4.8% ▲
1,196institutions hold it; the largest added shares

1,196 institutions hold 91% of Axon's shares (Jun 30, 2026); Vanguard, BlackRock and State Street added shares that quarter.

AXON in past recessions

pretickt analysis-8%its sales in the worst one

Axon's sales fell in 1 of the last 2 US recessions, by as much as 8% in fiscal 2008.

Price valuationIs the price reasonable?below its usual

AXON price vs profit P/E ratio

101.1×a year's earnings

Axon's P/E ratio is 101.1 (Nov 13, 2026), below its 3-year median of 131.2.

AXON price vs competitors

pretickt analysis101.1×a year's earnings, against its competitors

Investors pay 101.1 times Axon's earnings (Nov 13, 2026), more than for Woodward (36.7), Curtiss-Wright (31.5) or Textron (15.1).

AXON analysts' target price target

+103%to their average target

Analysts' average price target for Axon is $641, 103% above the Nov 13, 2026 close of $315.43.

AXON growth priced in fair value

pretickt analysis+46%a year, for ten years, to be worth the price

At $315.43 a share, Axon's free cash flow must grow about 46% a year for ten years to be worth the price (Nov 13, 2026).

What is Axon's P/E ratio?

Axon's P/E ratio is 101.1 (Nov 13, 2026), below its 3-year median of 131.2. Investors pay 101.1 times Axon's earnings (Nov 13, 2026), more than for Woodward (36.7), Curtiss-Wright (31.5) or Textron (15.1).

Who are Axon's biggest competitors?

pretickt compares Axon with Woodward, Curtiss-Wright, Rocket Lab and Textron. Axon's sales grew 34% in the 12 months to Sep 30, 2026, faster than Woodward (+22%), Curtiss-Wright (+11%) and Textron (+9%), slower than Rocket Lab (+59%).

Are insiders selling Axon stock?

Axon's executives and directors sold a net $119M of shares in the 12 months to Nov 13, 2026; none bought.

How does Axon make money?

Software And Sensors brought Axon 43% of its sales in fiscal 2025; TASER X2 33%.

Who owns Axon stock?

1,196 institutions hold 91% of Axon's shares (Jun 30, 2026); Vanguard, BlackRock and State Street added shares that quarter.

How many employees does Axon have?

Axon had 5,100 employees at the end of fiscal 2025, 24% more than a year before.

Who are Axon's biggest customers?

No customer made 10% of Axon's sales in fiscal 2025.

From the companies' statements (FMP), their filings read by pretickt, the analysts and the insiders, as of Nov 13, 2026. Each card says what a fact means for its question, never what to do with the stock: for information only, not investment advice.